Tocilizumab (RoActemra): rare risk of serious liver injury including cases requiring transplantation

2019-07-17T13:36:58+01:00

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels should be measured before starting treatment with tocilizumab and monitored every 4–8 weeks for the first 6 months of treatment followed by every 12 …